|
DK0817626T3
(da)
*
|
1995-03-27 |
1999-07-12 |
Assist Publ Hopitaux De Paris |
Anvendelse af fumagillol og derivater deraf til fremstilling af lægemidler mod tarminfektioner
|
|
AU4808997A
(en)
*
|
1996-09-30 |
1998-04-24 |
Brigham And Women's Hospital |
Methods and compounds for treatment of abnormal uterine bleeding
|
|
AU3352799A
(en)
*
|
1997-10-31 |
1999-08-23 |
Children's Medical Center Corporation |
Method for regulating size and growth of vascularized normal tissue
|
|
WO2000021560A1
(en)
*
|
1998-10-09 |
2000-04-20 |
Ludwig Institute For Cancer Research |
Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY
|
|
US7141607B1
(en)
*
|
2000-03-10 |
2006-11-28 |
Insite Vision Incorporated |
Methods and compositions for treating and inhibiting retinal neovascularization
|
|
WO2004022082A1
(ja)
*
|
2002-09-04 |
2004-03-18 |
Proteinexpress Co., Ltd. |
胚着床制御剤
|
|
US20040266688A1
(en)
*
|
2003-05-14 |
2004-12-30 |
Nayak Nihar R |
Methods for modulating endometrium
|
|
NZ545188A
(en)
*
|
2003-07-14 |
2008-12-24 |
Fusion Sport Internat Pty Ltd |
Sports training and testing methods, apparatus and system
|
|
US7524811B2
(en)
*
|
2003-08-29 |
2009-04-28 |
Children's Medical Center Corporation |
Anti-angiogenic peptides from the N-terminus of endostatin
|
|
JP2007529410A
(ja)
*
|
2003-08-29 |
2007-10-25 |
チルドレンズ メディカル センター コーポレーション |
子宮内膜症を治療又は防止するためのペプチド
|
|
CN102099491A
(zh)
*
|
2008-05-15 |
2011-06-15 |
北卡罗来纳-查佩尔山大学 |
调节血管生成的新靶标
|
|
EP2140860A1
(en)
|
2008-07-03 |
2010-01-06 |
Bayer Schering Pharma Oy |
An improved method of contraception
|
|
EP2317845A4
(en)
|
2008-07-18 |
2011-11-09 |
Zafgen Inc |
METHOD FOR TREATING AN OVERWEIGHT OR FATABLE PERSON
|
|
WO2010012002A1
(en)
*
|
2008-07-25 |
2010-01-28 |
Saryna Medical Corporation |
Methods and systems for genetic analysis of fetal nucleated red blood cells
|
|
US8642650B2
(en)
|
2008-12-04 |
2014-02-04 |
Zafgen, Inc. |
Methods of treating an overweight or obese subject
|
|
WO2010065877A2
(en)
|
2008-12-04 |
2010-06-10 |
Zafgen Corporation |
Methods of treating an overweight or obese subject
|
|
AU2010303270A1
(en)
|
2009-10-09 |
2012-05-03 |
Zafgen Corporation |
Sulphone compounds for use in the treatment of obesity
|
|
MX343135B
(es)
|
2010-01-08 |
2016-10-25 |
Zafgen Corp * |
Compuestos de tipo fumagilol y métodos de realización y uso de los mismos.
|
|
US8815309B2
(en)
|
2010-01-08 |
2014-08-26 |
Zafgen, Inc. |
Methods of treating a subject with benign prostate hyperplasia
|
|
RU2427325C1
(ru)
*
|
2010-01-29 |
2011-08-27 |
Государственное образовательное учреждение высшего профессионального образования "Астраханская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО АГМА Росздрава) |
Способ оценки эффективности лечения хронической плацентарной недостаточности в эксперименте
|
|
US8774488B2
(en)
|
2010-03-11 |
2014-07-08 |
Cellscape Corporation |
Method and device for identification of nucleated red blood cells from a maternal blood sample
|
|
WO2011127304A2
(en)
|
2010-04-07 |
2011-10-13 |
Zafgen Corporation |
Methods of treating an overweight subject
|
|
CN103079567A
(zh)
|
2010-04-17 |
2013-05-01 |
拜尔健康护理有限责任公司 |
用于疾病和病症的治疗和预防的氟取代的ω-羧基芳基二苯脲的合成代谢产物
|
|
WO2012012404A1
(en)
|
2010-07-19 |
2012-01-26 |
Bayer Healthcare Llc |
Drug combinations with fluoro-substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
|
|
WO2012012642A1
(en)
|
2010-07-22 |
2012-01-26 |
Zafgen Corporation |
Tricyclic compounds and methds of making and using same
|
|
PH12013500934A1
(en)
|
2010-11-09 |
2022-10-24 |
Zafgen Inc |
Crystalline solids of a metap-2 inhibitor and methods of making and using same
|
|
CA2819251A1
(en)
|
2010-11-29 |
2012-06-07 |
Zafgen Corporation |
Treatment of obesity using non-daily administration of 6 - 0 - (4 - dimethylaminoethoxy) cinnamoyl fumagillol
|
|
WO2012103333A1
(en)
|
2011-01-26 |
2012-08-02 |
Zafgen Corporation |
Tetrazole compounds and methods of making and using same
|
|
JP5876513B2
(ja)
|
2011-03-08 |
2016-03-02 |
ザフゲン，インコーポレイテッド |
オキサスピロ［２．５］オクタン誘導体および類似体
|
|
CN103764652B
(zh)
|
2011-05-06 |
2016-03-23 |
扎夫根股份有限公司 |
三环吡唑磺酰胺化合物及其制备和使用方法
|
|
US9290472B2
(en)
|
2011-05-06 |
2016-03-22 |
Zafgen, Inc. |
Partially saturated tricyclic compounds and methods of making and using same
|
|
BR112013028665A2
(pt)
|
2011-05-06 |
2016-09-06 |
Zafgen Inc |
compostos de sulfonamida tricíclicos e métodos para fazer e usar os mesmos
|
|
EP2763671A2
(en)
|
2011-10-03 |
2014-08-13 |
Zafgen, Inc. |
Methods of treating age related disorders
|
|
CA2861381A1
(en)
|
2012-01-18 |
2013-07-25 |
Zafgen, Inc. |
Tricyclic sulfone compounds and methods of making and using same
|
|
CA2861390A1
(en)
|
2012-01-18 |
2013-07-25 |
Zafgen, Inc. |
Tricyclic sulfonamide compounds and methods of making and using same
|
|
WO2013169727A1
(en)
|
2012-05-07 |
2013-11-14 |
Zafgen, Inc. |
Polymorphic salt of the oxalate salt of 6 - o - ( 4 - dimethylaminoethoxy) cinnarnoyl fumagillol and methods of making and using same
|
|
MX2014013599A
(es)
|
2012-05-08 |
2015-05-11 |
Zafgen Inc |
Tratamiento de la obesidad hipotalamica con inhibidores de metap2.
|
|
US9573918B2
(en)
|
2012-05-09 |
2017-02-21 |
Zafgen, Inc. |
Fumigillol compounds and methods of making and using same
|
|
NZ707773A
(en)
|
2012-11-05 |
2019-05-31 |
Zafgen Inc |
Methods of treating liver diseases
|
|
KR20150080614A
(ko)
|
2012-11-05 |
2015-07-09 |
자프겐 인크. |
비만의 치료 및/또는 제어에서 사용하기 위한 트리시클릭 화합물
|
|
MX2015005732A
(es)
|
2012-11-05 |
2015-12-16 |
Zafgen Inc |
Compuestos tricíclicos y métodos para hacer y utilizar los mismos.
|
|
BR112015023390A2
(pt)
|
2013-03-14 |
2017-07-18 |
Zafgen Inc |
métodos para tratar de doença renal e outros distúrbios
|
|
CN106432255A
(zh)
|
2015-08-11 |
2017-02-22 |
扎夫根公司 |
烟曲霉素醇螺环化合物和制备和使用其的方法
|
|
AR105671A1
(es)
|
2015-08-11 |
2017-10-25 |
Zafgen Inc |
Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso
|